We present our experience of the Impella 2.5 as an adjunct for left ventricular unloading during peripheral VA ECMO support and as a bridge for the HeartMate II left ventricular assist device (LVAD).
Intravenous enoxaparin has been found to increase activated clotting time (ACT) at 5 minutes in patients undergoing percutaneous coronary intervention (PCI), indicating […]